STAAR Surgical Company

STAA

US8523123052

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-11 pm EST			5-day change	1st Jan Change
17.25 ^USD	-0.29%		-4.96%	-25.29%

Feb. 05	Staar Surgical Co - Enters agreement with Chief Legal Officer Nathaniel Sisitsky - SEC filing	RE
Feb. 03	Wedbush Initiates STAAR Surgical Company at Neutral With $26 Price Target	MT

Alcon Exercises Right to Require STAAR Surgical to Delay Stockholder Meeting

Published on 12/19/2025 at 12:31 pm EST

MT Newswires

Latest news about STAAR Surgical Company

Feb. 05	Staar Surgical Co - Enters agreement with Chief Legal Officer Nathaniel Sisitsky - SEC filing	RE
Feb. 03	Wedbush Initiates STAAR Surgical Company at Neutral With $26 Price Target	MT
Feb. 02	Staar Surgical appoints Warren Foust & Deborah Andrews interim co-CEOs	RE
Feb. 02	STAAR Surgical Names Warren Foust, Deborah Andrews as Interim Co-CEOs	MT
Feb. 02	STAAR Surgical Company Announces Interim Co-CEO Appointments, Effective February 1, 2026	CI
Jan. 16	Staar Surgical Company Announces Board and Committee Changes, Effective January 15, 2026	CI
Jan. 15	STAAR Surgical Chair, CEO Step Down From Board as Part of Cooperation Agreement With Broadwood	MT
Jan. 15	STAAR Surgical Company Announces Board Changes, Effective January 15, 2026	CI
Jan. 15	STAAR Surgical Company Announces Stephen Farrell Steps Down as CEO, Effective January 31, 2026	CI
Jan. 15	Staar Surgical CEO to exit as part of deal with top shareholder	RE
Jan. 15	Staar Surgical and Broadwood Partners enter into cooperation agreement	RE
Jan. 07	Alcon Terminates Merger Deal With STAAR Surgical	MT
Jan. 07	Alcon terminates agreement to acquire STAAR Surgical	RE
Jan. 07	Swiss stocks - Factors to watch on January 7	RE
Jan. 06	Alcon Scraps Takeover Plans for US-based Staar Surgical	MT
Jan. 06	STAAR Surgical Company Shareholders Reject Merger Proposal with Alcon Research, LLC	CI
Jan. 06	STAAR Surgical Company Shareholders Reject Merger Proposal with Alcon Research	CI
Jan. 06	STAAR Surgical Company Shareholders Reject Merger Proposal with Alcon Research	CI
Jan. 06	Sector Update: Health Care Stocks Gain Tuesday Afternoon	MT
Jan. 06	European Equities Rise Tuesday; Anheuser-Busch to Reacquire US Metal Container Plants Stake	MT
Jan. 06	Swiss Market Index Bounces Back; Alcon Shares Gain	MT
Jan. 06	Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing	RE
Jan. 06	Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win	DJ
Jan. 06	Staar Surgical did not receive votes to approve Alcon merger at special meeting of stockholders	RE
Jan. 06	STAAR Surgical Shareholders Reject Proposed Alcon Merger; Shares Fall	MT

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Companyâ€™s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.

Employees

1,157

Sector

Medical Equipment, Supplies & Distribution

Calendar

Feb. 24 - Q4 2025 Earnings Release (Projected)

More about the company